Primary study · included by 1 review
Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8+ T cells.
Wang M 2023 · Wang Mengyao, Zhai Rundong, Wang Mengqi, et al. · Molecular oncology · 2023
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Overall survival Absence of tertiary lymphoid structures (TLS-negative tumors) vs Presence of tertiary lymphoid structures (TLS-positive tumors, reference category) · Follow-up 24 to 120 months | HR 2.20 [1.74, 2.78] | 7 studies · 1465 participants | GRADE not reported |
Disease-free survival Absence of tertiary lymphoid structures (TLS-negative tumors) vs Presence of tertiary lymphoid structures (TLS-positive tumors, reference category) · Follow-up 24 to 120 months | HR 2.21 [1.49, 3.28] | 3 studies · 453 participants | GRADE not reported |
1 including review in total.